Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Burden and Unmet Needs Associated with Desmoid Tumors
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ongoing treatment challenges.
EP: 1.Key Background Information on Desmoid Tumors
EP: 2.Exploring the Heterogeneous Nature of Desmoid Tumors
EP: 3.The Role of Molecular Biomarkers in Diagnosing Desmoid Tumors
Now Viewing
EP: 4.The Burden and Unmet Needs Associated with Desmoid Tumors
EP: 5.When to Observe Desmoid Tumors
EP: 6.Surgery, Cryotherapy, and Radiotherapy for Desmoid Tumors
EP: 7.Novel Pharmacotherapies and NCCN Guideline Recommendations
EP: 8.Examining a Novel FDA-approved Therapy in Desmoid Tumors
EP: 9.Dose Reducing and Sequencing Therapies in Desmoid Tumors
EP: 10.Insurance Coverage and Patient Education
EP: 11.Additional Clinical Considerations for Desmoid Tumors
EP: 12.Optimizing Patient Care and the Potential of Artificial Intelligence
EP: 13.Unmet Needs and the Future of Desmoid Tumor Management
Panelists discuss the questions below in this video.
- There any molecular biomarkers that are commonly associated with desmoid tumor?
- What is the role of biomarker testing in patients with suspected diagnosis? What makes the definitive diagnosis?
Related Videos
Related Content
